| Literature DB >> 35649618 |
Thi Ninh Ha1, Sviatlana Kamarova2, David Youens1, Cameron Wright3,4,5,6, Donald McRobbie7, Jenny Doust8, John Slavotinek9, Max K Bulsara10,11, Rachael Moorin1,11.
Abstract
OBJECTIVE: High use of CT scanning has raised concern due to the potential ionising radiation exposure. This study examined trends of CT during admission to tertiary hospitals and its associations with length of stay (LOS), readmission and mortality.Entities:
Keywords: epidemiology; health policy; quality in health care; radiology & imaging
Mesh:
Year: 2022 PMID: 35649618 PMCID: PMC9161060 DOI: 10.1136/bmjopen-2021-059242
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1JoinPoint regression the trend in (A) any CT, (B) multiple CT and (C) repeat CT. (A) Per 1000 tertiary episodes of hospitalisations, (B) and (C) per 1000 tertiary episodes of hospitalisations with at least one CT.
Characteristics of the study population in 2003 and 2015 by CT status
| Characteristics | 2003 | 2015 | ||||||||||||||
| Total | At least one CT scan | Multiple scanning | Repeat CT scanning | Total | At least one CT scan | Multiple scanning | Repeat CT scanning | |||||||||
| N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | |
| Overall | 165 598 | 100 | 14 118 | 8.5 | 3 799 | 26.9 | 1 739 | 12.3 | 189 170 | 100 | 33 178 | 17.5 | 9 171 | 27.6 | 3 427 | 10.3 |
| Sex | ||||||||||||||||
| Male | 82 056 | 49.6 | 7 502 | 9.1 | 2 143 | 28.6 | 964 | 12.8 | 91 770 | 48.5 | 17 910 | 19.5 | 5 377 | 30.0 | 2 082 | 11.6 |
| Female | 83 542 | 50.4 | 6 616 | 7.9 | 1 656 | 25.0 | 775 | 11.7 | 97 400 | 51.5 | 15 268 | 15.7 | 3 794 | 24.8 | 1 345 | 8.8 |
| Age groups | ||||||||||||||||
| 18–44 | 47 389 | 28.6 | 3 422 | 7.2 | 899 | 26.27 | 435 | 12.7 | 54 198 | 28.7 | 6 760 | 12.5 | 1 844 | 27.3 | 705 | 10.4 |
| 45–64 | 49 946 | 30.2 | 3 830 | 7.7 | 1 097 | 28.64 | 498 | 13.0 | 58 436 | 30.9 | 9 409 | 16.1 | 2 679 | 28.5 | 1 032 | 10.9 |
| 65+ | 68 263 | 41.2 | 6 866 | 10.1 | 1 803 | 26.26 | 806 | 11.7 | 76 536 | 40.5 | 17 009 | 22.2 | 4 648 | 27.3 | 1 690 | 9.9 |
| SEIFA | ||||||||||||||||
| Least disadvantage | 51 357 | 31.0 | 4 161 | 8.1 | 1 051 | 25.26 | 523 | 12.6 | 45 951 | 24.3 | 8 973 | 19.5 | 2 326 | 25.9 | 849 | 9.5 |
| Less disadvantage | 32 570 | 19.7 | 2 725 | 8.4 | 748 | 27.45 | 338 | 12.4 | 38 804 | 20.5 | 6 617 | 17.0 | 1 784 | 26.9 | 655 | 9.9 |
| Moderate disadvantage | 17 322 | 10.5 | 1 616 | 9.3 | 437 | 27.04 | 187 | 11.6 | 36 354 | 19.2 | 6 455 | 17.7 | 1 714 | 26.5 | 625 | 9.7 |
| Highly/highest disadvantage | 63 501 | 38.3 | 5 523 | 8.7 | 1 530 | 27.70 | 676 | 12.2 | 66 754 | 35.3 | 10 974 | 16.4 | 3 290 | 29.9 | 1 279 | 11.6 |
| Unknown | 848 | 0.5 | 93 | 10.9 | 33 | 35.48 | 15 | 16.1 | 1 307 | 0.7 | 159 | 12.2 | 57 | 35.8 | 19 | 11.9 |
| ARIA | ||||||||||||||||
| Major cities | 143 290 | 86.5 | 11 570 | 8.1 | 2 914 | 25.19 | 1 343 | 11.6 | 165 076 | 87.3 | 29 395 | 17.8 | 7 841 | 26.7 | 2 836 | 9.6 |
| Inner regional areas | 10 279 | 6.2 | 1 138 | 11.1 | 380 | 33.39 | 181 | 15.9 | 7 497 | 4.0 | 1 193 | 15.9 | 430 | 36.0 | 196 | 16.4 |
| Outer regional areas | 5 993 | 3.6 | 679 | 11.3 | 237 | 34.90 | 102 | 15.0 | 7 921 | 4.2 | 1 304 | 16.5 | 471 | 36.1 | 208 | 15.9 |
| Remote and very remote areas | 5 641 | 3.4 | 693 | 12.3 | 259 | 37.37 | 109 | 15.7 | 7 290 | 3.9 | 1 107 | 15.2 | 371 | 33.5 | 168 | 15.2 |
| Admission type | ||||||||||||||||
| Elective | 101 471 | 61.3 | 1 988 | 1.9 | 731 | 36.77 | 204 | 10.3 | 82 446 | 43.6 | 3 316 | 4.0 | 826 | 24.9 | 344 | 10.4 |
| Emergency | 64 127 | 38.7 | 12 130 | 18.9 | 3 068 | 25.29 | 1 535 | 12.6 | 106 724 | 56.4 | 29 862 | 27.9 | 8 345 | 27.9 | 3 083 | 10.3 |
| Comorbidities | ||||||||||||||||
| 0–1 | 35 602 | 21.5 | 1 985 | 5.6 | 387 | 19.50 | 85 | 4.3 | 40 839 | 21.6 | 4 470 | 10.9 | 646 | 14.5 | 133 | 2.9 |
| 2–5 | 120 272 | 72.6 | 8 393 | 6.9 | 1 885 | 22.46 | 744 | 8.8 | 128 109 | 67.7 | 18 893 | 14.7 | 4 409 | 23.3 | 1 235 | 6.5 |
| 6+ | 9 724 | 5.9 | 3 740 | 38.5 | 1 527 | 40.83 | 910 | 24.3 | 20 222 | 10.7 | 9 815 | 48.5 | 4 116 | 41.9 | 2 059 | 20.9 |
| Involving surgical procedures | ||||||||||||||||
| No | 159 530 | 96.3 | 13 095 | 8.2 | 3 469 | 26.49 | 1 555 | 11.9 | 177 170 | 93.7 | 30 627 | 17.3 | 8 268 | 27.0 | 2 991 | 9.8 |
| Yes | 6 068 | 3.7 | 1 023 | 16.9 | 330 | 32.26 | 184 | 17.9 | 12 000 | 6.3 | 2 551 | 21.3 | 903 | 35.4 | 436 | 17.1 |
| Diagnosis chapter with a high frequent use of CT | ||||||||||||||||
| Others | 84 013 | 50.7 | 1 206 | 1.4 | 300 | 24.88 | 83 | 6.9 | 73 298 | 38.7 | 2 479 | 3.4 | 649 | 26.2 | 145 | 5.8 |
| Infectious | 1 744 | 1.1 | 352 | 20.2 | 98 | 27.84 | 51 | 14.5 | 3 632 | 1.9 | 1 105 | 30.4 | 318 | 28.8 | 112 | 10.1 |
| Neoplasm | 12 168 | 7.3 | 1 883 | 15.5 | 914 | 48.54 | 285 | 15.1 | 14 235 | 7.5 | 2 974 | 20.9 | 1 164 | 39.1 | 411 | 13.8 |
| Mental | 4 283 | 2.6 | 708 | 16.5 | 56 | 7.91 | 28 | 3.9 | 5 763 | 3.0 | 1 174 | 20.4 | 216 | 18.4 | 56 | 4.8 |
| Nervous system | 2 688 | 1.6 | 793 | 29.5 | 103 | 12.99 | 71 | 8.9 | 4 928 | 2.6 | 1 622 | 32.9 | 344 | 21.2 | 138 | 8.5 |
| Ear and mastoid | 478 | 0.3 | 91 | 19.0 | 8 | 8.79 | NP | 757 | 0.4 | 332 | 43.8 | 44 | 13.3 | 7 | 2.1 | |
| Circulatory system | 13 875 | 8.4 | 2 191 | 15.8 | 683 | 31.17 | 460 | 20.9 | 17 207 | 9.1 | 4 406 | 25.6 | 1 460 | 33.1 | 773 | 17.5 |
| Respiratory | 5 838 | 3.5 | 861 | 14.7 | 211 | 24.51 | 69 | 8.0 | 7 959 | 4.2 | 2 007 | 25.2 | 347 | 17.3 | 108 | 5.4 |
| Digestive | 11 617 | 7.0 | 1 487 | 12.8 | 309 | 20.78 | 183 | 12.3 | 15 473 | 8.2 | 3 867 | 24.9 | 773 | 19.9 | 422 | 10.9 |
| Genitourinary | 6 323 | 3.8 | 754 | 11.9 | 70 | 9.28 | 28 | 3.7 | 8 443 | 4.5 | 1 939 | 22.9 | 210 | 10.8 | 82 | 4.2 |
| Congenital | 345 | 0.2 | 39 | 11.3 | 15 | 38.46 | NP | 405 | 0.2 | 64 | 15.8 | 18 | 28.1 | 14 | 21.9 | |
| Symptom/signs | 8 277 | 5.0 | 1 235 | 14.9 | 176 | 14.25 | 36 | 2.9 | 14 055 | 7.4 | 3 862 | 27.5 | 567 | 14.7 | 117 | 3.0 |
| Injury/poison | 13 949 | 8.4 | 2 518 | 18.1 | 856 | 34.00 | 433 | 17.2 | 23 015 | 12.2 | 7 347 | 31.9 | 3 061 | 41.7 | 1 042 | 14.2 |
| Length of stay (median, IQR) | 1 | 1–4 | 9 | 4–19 | 15 | 7–33 | 24 | 13–47 | 2 | 1–4 | 4 | 2–9 | 8 | 3–17 | 14 | 7–28 |
Any CT scanning: an episode of admission with any CT scanning; multiple CT scans: an episode of admission with two or more CT scans; repeat CT scanning: an episode of admission with two or more CT scans in the same anatomical area.
Others include disease of blood and blood forming organs; disease of the eyes and adnexa; disease of the skin and subcutaneous tissue; disease of the musculoskeletal system and connective tissue; and pregnancy and childbirth.
ARIA, accessibility and remoteness index of Australia; NP, not provided; SEIFA, socioeconomic indexes for areas.
Factors associated with any, multiple or repeat CT in tertiary hospitals
| Any CT scanning | Multiple CT scans | Repeat CT scanning | ||||
| IRR | 95% CI | IRR | 95% CI | IRR | 95% CI | |
| Year | ||||||
| 2003 | 1 | (1 to 1) | 1 | (1 to 1) | 1 | (1 to 1) |
| 2004 | 1.04*** | (1.02 to 1.07) | 0.99 | (0.94 to 1.03) | 0.97 | (0.91 to 1.04) |
| 2005 | 1.06*** | (1.03 to 1.08) | 0.94** | (0.90 to 0.98) | 0.92* | (0.87 to 0.99) |
| 2006 | 1.12*** | (1.09 to 1.14) | 0.94** | (0.90 to 0.98) | 0.94* | (0.88 to 1.00) |
| 2007 | 1.18*** | (1.15 to 1.20) | 0.94** | (0.90 to 0.98) | 0.96 | (0.90 to 1.02) |
| 2008 | 1.25*** | (1.22 to 1.28) | 0.96 | (0.92 to 1.00) | 0.93* | (0.87 to 0.99) |
| 2009 | 1.25*** | (1.22 to 1.28) | 0.99 | (0.95 to 1.03) | 0.94 | (0.88 to 1.00) |
| 2010 | 1.26*** | (1.23 to 1.28) | 0.98 | (0.94 to 1.02) | 0.89*** | (0.84 to 0.95) |
| 2011 | 1.27*** | (1.24 to 1.29) | 0.99 | (0.95 to 1.03) | 0.89*** | (0.83 to 0.94) |
| 2012 | 1.30*** | (1.28 to 1.33) | 0.98 | (0.94 to 1.02) | 0.83*** | (0.78 to 0.88) |
| 2013 | 1.37*** | (1.35 to 1.40) | 1.00 | (0.96 to 1.04) | 0.82*** | (0.77 to 0.87) |
| 2014 | 1.42*** | (1.40 to 1.45) | 0.98 | (0.95 to 1.02) | 0.78*** | (0.74 to 0.83) |
| 2015 | 1.46*** | (1.43 to 1.49) | 1.03 | (0.99 to 1.07) | 0.83*** | (0.79 to 0.88) |
| Sex | ||||||
| Male | 1 | (1 to 1) | 1 | (1 to 1) | 1 | (1 to 1) |
| Female | 0.90*** | (0.89 to 0.90) | 0.87*** | (0.86 to 0.88) | 0.85*** | (0.83 to 0.87) |
| Age group | ||||||
| 18–44 years | 1 | (1 to 1) | 1 | (1 to 1) | 1 | (1 to 1) |
| 45–64 years | 1.25*** | (1.24 to 1.27) | 0.96*** | (0.94 to 0.98) | 0.85*** | (0.82 to 0.88) |
| 65+ years | 1.30*** | (1.29 to 1.31) | 0.81*** | (0.79 to 0.82) | 0.59*** | (0.57 to 0.61) |
| ARIA | ||||||
| Major cities | 1 | (1 to 1) | 1 | (1 to 1) | 1 | (1 to 1) |
| Inner regional areas | 1.05*** | (1.03 to 1.06) | 1.13*** | (1.10 to 1.17) | 1.24*** | (1.19 to 1.30) |
| Outer regional areas | 1.12*** | (1.10 to 1.14) | 1.14*** | (1.11 to 1.18) | 1.16*** | (1.10 to 1.21) |
| Remote and very remote areas | 1.21*** | (1.18 to 1.23) | 1.14*** | (1.10 to 1.18) | 1.19*** | (1.13 to 1.26) |
| Unknown | 0.66*** | (0.60 to 0.73) | 1.02 | (0.86 to 1.21) | 0.71* | (0.53 to 0.94) |
| SEIFA | ||||||
| Least disadvantage | 1 | (1 to 1) | 1 | (1 to 1) | 1 | (1 to 1) |
| Less disadvantage | 0.99* | (0.98 to 1.00) | 1.00 | (0.98 to 1.02) | 0.97 | (0.94 to 1.01) |
| Moderate disadvantage | 0.99* | (0.98 to 1.00) | 1.00 | (0.98 to 1.02) | 0.96* | (0.93 to 1.00) |
| Highly/highest disadvantage | 0.99** | (0.98 to 1.00) | 1.01 | (0.99 to 1.03) | 0.97* | (0.94 to 1.00) |
| Unknown | 1.01 | (0.94 to 1.09) | 1.06 | (0.93 to 1.20) | 1.11 | (0.92 to 1.34) |
| Number of morbidity | ||||||
| 0–1 | 1 | (1 to 1) | 1 | (1 to 1) | 1 | (1 to 1) |
| 2–5 | 1.42*** | (1.41 to 1.44) | 1.61*** | (1.57 to 1.66) | 2.68*** | (2.53 to 2.84) |
| 6+ | 2.90*** | (2.87 to 2.94) | 2.96*** | (2.88 to 3.05) | 8.51*** | (8.03 to 9.03) |
| Admission type | ||||||
| Elective | 1 | (1 to 1) | 1 | (1 to 1) | 1 | (1 to 1) |
| Emergency | 5.35*** | (5.28 to 5.41) | 1.20*** | (1.17 to 1.23) | 1.16*** | (1.11 to 1.20) |
| Involving surgical procedure | ||||||
| No | 1 | (1 to 1) | 1 | (1 to 1) | 1 | (1 to 1) |
| Yes | 0.85*** | (0.83 to 0.86) | 1.02* | (1.00 to 1.05) | 1.13*** | (1.09 to 1.17) |
| Diagnosis chapter with a high frequent use of CT | ||||||
| Others† | 1 | (1 to 1) | 1 | (1 to 1) | 1 | (1 to 1) |
| Infectious | 3.09*** | (3.02 to 3.17) | 1.01 | (0.96 to 1.06) | 1.40*** | (1.29 to 1.52) |
| Neoplasm | 5.63*** | (5.54 to 5.73) | 1.84*** | (1.79 to 1.90) | 2.27*** | (2.14 to 2.40) |
| Mental | 2.37*** | (2.31 to 2.42) | 0.56*** | (0.53 to 0.59) | 0.73*** | (0.66 to 0.81) |
| Nervous system | 6.11*** | (5.98 to 6.24) | 0.79*** | (0.75 to 0.83) | 1.57*** | (1.46 to 1.69) |
| Ear and mastoid | 7.05*** | (6.77 to 7.34) | 0.62*** | (0.55 to 0.70) | 0.86 | (0.69 to 1.08) |
| Circulatory system | 3.16*** | (3.10 to 3.21) | 1.25*** | (1.22 to 1.29) | 2.96*** | (2.80 to 3.12) |
| Respiratory | 2.55*** | (2.50 to 2.60) | 0.86*** | (0.82 to 0.89) | 1.07 | (0.99 to 1.15) |
| Digestive | 3.47*** | (3.41 to 3.53) | 0.85*** | (0.82 to 0.88) | 1.81*** | (1.71 to 1.92) |
| Genitourinary | 3.69*** | (3.62 to 3.76) | 0.45*** | (0.42 to 0.47) | 0.83*** | (0.76 to 0.91) |
| Congenital | 6.40*** | (5.95 to 6.89) | 1.31*** | (1.14 to 1.52) | 3.73*** | (3.14 to 4.43) |
| Symptom/signs | 3.84*** | (3.78 to 3.91) | 0.58*** | (0.55 to 0.60) | 0.66*** | (0.61 to 0.71) |
| Injury/poison | 3.69*** | (3.63 to 3.74) | 1.60*** | (1.56 to 1.65) | 2.46*** | (2.33 to 2.60) |
Any CT scanning: an episode of admission with any CT scanning; multiple CT scans: an episode of admission with two or more CT scans; repeat CT scanning: an episode of admission with two or more CT scans in the same anatomical areas.
*P value <0.05; **p value <0.01, ***p value <0.001. All models were adjusted with Indigenous status, but the data are not shown.
†Others include disease of blood and blood forming organs; disease of the eyes and adnexa; disease of the skin and subcutaneous tissue; disease of the musculoskeletal system and connective tissue; and pregnancy and childbirth.
ARIA, accessibility and remoteness index of Australia; IRR, Incidence Rate Ratio; SEIFA, socioeconomic indexes for areas.
Figure 2Trends in length of stay (days) for hospitalisations with and without CT. (A) The adjusted rate for tertiary length of stay between hospital admissions with and without CT for any, multiple and repeat CT. (B) The rate difference in tertiary length of stay between hospital admissions with and without CT for any, multiple and repeat CT relative to the rate difference in 2003 for each group.
Figure 3Trends in the rate of 30-day readmissions for hospitalisations with and without CT. (A) The adjusted rate for 30-day readmissions with and without CT for any, multiple and repeat CT. (B) The rate difference for 30-day readmission between those with and without CT for any, multiple and repeat CT relative to the rate difference in 2003 for each group.
Figure 4Trends in the rate of 30-day mortality after discharge for hospitalisations with and without CT. (A) The adjusted probability of 30-day mortality after discharge for hospitalisations with and without CT for any, multiple and repeat CT. (B) The rate difference probability of 30-day mortality after discharge between hospitalisations with and without CT for any, multiple and repeat CT relative to the difference in 2003 for each group.